The chapters in this book confront the controversy over biotechnology with new analyses and insights from economists and technologists. The topics covered include the differences in perceptions about biotechnology among rich and poor countries; the effects of rich-country restrictions on international trade in genetically modified crops on the welfare of poorer countries; the promise of alternative technologies; the effects of intellectual property rights on the bioscience done by public agencies the world over; and the economic impacts of biotechnology past, present, and future.
The chapters address questions such as, How much should be invested in the new biosciences? Who should perform the research and pay for it? Who are the likely users -- as well as the likely winners and losers? Policymakers and partisans on both sides of the debate will find in this book useful economic ways of thinking about the tradeoffs of biotechnology.